MARINOQUINOLINES AS ANTICANCER AGENTS: DISCOVERY OF NEW HIGHLY ACTIVE AND SELECTIVE DERIVATIVES

Vol. 1, 2019 - 108960
Poster and Oral (selected)
Favorite this paper
How to cite this paper?
Abstract

Marinoquinolines represent a new class of natural and unnatural compounds containing the uncommon 3H-pyrrolo[2,3-c]quinoline scaffold which has rarely been studied. In 2012, our research group reported the total synthesis of the natural marinoquinolines A, B, C and E, and this synthetic procedure allowed the synthesis of new unnatural derivatives. In light of these results, we have been working on the synthesis of new analogues in order to set up a small library of compounds and exploit the medicinal potencial of the marinoquinoline class, specifically for cancer. A HTS-compatible assay for HaCat and HCT-116 cell lines was performed and a hit compounds was selected, with high potency (3.1 ± 0.5 μM) and selectivity (>100 μM). A second part of the study was trying to doing some molecular modifications in order to improve potency of this compound.

Institutions
  • 1 Instituto de Química / Universidade Estadual de Campinas
  • 2 (CNPEM) Centro Nacional de Pesquisa em Energia e Materiais
Track
  • 2. Medicinal Chemistry of Synthetic Compounds
Keywords
Drug Discovery
Organic Synthesis
Antitumor activity